Provided by Tiger Trade Technology Pte. Ltd.

Quoin Pharmaceuticals

6.87
+0.07001.03%
Volume:29.26K
Turnover:199.71K
Market Cap:13.80M
PE:-0.81
High:6.99
Open:6.83
Low:6.75
Close:6.80
52wk High:41.80
52wk Low:3.25
Shares:2.01M
Float Shares:1.30M
Volume Ratio:0.85
T/O Rate:2.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5210
EPS(LYR):-14.7963
ROE:-575.73%
ROA:-114.60%
PB:3.51
PE(LYR):-0.46

Loading ...

Sep 10, 2026

Major Issues Report

Form 8-K - Current report
Aug 28, 2026

Major Issues Report

Form 8-K - Current report
Aug 20, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Jun 23, 2026

Major Issues Report

Form 8-K - Current report
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
Jun 02, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2026

Major Issues Report

Form 8-K - Current report
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 20, 2026

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Correspondence

Form CORRESP - Correspondence
Nov 18, 2025

Major Issues Report

Form 8-K - Current report